Sensitive high-performance liquid chromatographic determination of famotidine in plasma. Application to pharmacokinetic study.
A sensitive high-performance liquid chromatographic (HPLC) method for the quantitation of famotidine in human plasma is described. Clopamide was used as the internal standard. Plasma samples were extracted with diethyl ether to eliminate endogenous interferences. Plasma samples were then extracted at alkaline pH with ethyl acetate. Famotidine and the internal standard were readily extracted into the organic solvent. After evaporation of ethyl acetate, the residue was analysed by HPLC. The chromatographic separation was accomplished with an isocratic mobile phase consisting of acetonitrile-water (12:88, v/v) containing 20 mM disodium hydrogenphosphate and 50 mM sodium dodecyl sulphate, adjusted to pH 3. The HPLC microbore column was packed with 5 microns ODS Hypersil. Using ultraviolet detection at 267 nm, the detection limit for plasma famotidine was 5 ng/ml. The calibration curve was linear over the concentration range 5-500 ng/ml. The inter- and intra-assay coefficients of variation were found to be less than 10%. Applicability of the method was demonstrated by a bioavailability/pharmacokinetic study in normal volunteers who received 80 mg famotidine orally.
Wanwimolruk
S
S
School of Pharmacy, University of Otago, Dunedin, New Zealand.
Zoest
A R
AR
Wanwimolruk
S Z
SZ
Hung
C T
CT
D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D003005:Clopamide / Q000097:blood; D015738:Famotidine / Q000097:blood* / Q000493:pharmacokinetics; D006801:Humans; D012015:Reference Standards; D012016:Reference Values; D015203:Reproducibility of Results; D013056:Spectrophotometry, Ultraviolet
D003005:Clopamide; D015738:Famotidine